Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
8.56
+0.82 (10.59%)
Nov 24, 2025, 4:00 PM EST - Market closed

Passage Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
273555753441,164
Upgrade
Market Cap Growth
-32.36%-36.73%-26.45%-78.09%-70.49%-
Upgrade
Enterprise Value
-1-24-51-111-11829
Upgrade
Last Close Price
8.5611.3420.2027.60127.00511.40
Upgrade
PB Ratio
0.870.570.500.371.083.82
Upgrade
P/TBV Ratio
0.870.570.500.371.083.82
Upgrade
Debt / Equity Ratio
0.780.420.240.14--
Upgrade
Quick Ratio
2.373.966.9910.3310.7114.40
Upgrade
Current Ratio
2.514.077.2210.7411.0214.98
Upgrade
Return on Equity (ROE)
-87.18%-75.07%-65.29%-52.35%-59.48%-46.85%
Upgrade
Return on Assets (ROA)
-31.66%-32.20%-32.67%-27.00%-32.52%-27.61%
Upgrade
Return on Capital (ROIC)
-38.22%-36.31%-35.17%-29.54%-35.64%-29.20%
Upgrade
Return on Capital Employed (ROCE)
-90.70%-78.50%-76.70%-57.40%-54.60%-36.50%
Upgrade
Earnings Yield
-166.35%-184.90%-184.34%-180.82%-53.96%-9.64%
Upgrade
FCF Yield
-123.07%-137.00%-141.62%-160.04%-42.06%-7.01%
Upgrade
Buyback Yield / Dilution
-4.38%-10.34%-0.58%-2.03%-38.14%-811.60%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q